70 F
New York
Monday, September 28, 2020

Barclays PLC (NYSE:BCS) is Holding Steady

Must read

Investor Confidence is Rising for Cellect Biotechnology Ltd. (NASDAQ:APOP)

Cellect Biotechnology Ltd. (APOP) shares are trading at higher $2.49. To add more color to this target, the company’s high over the last year...

The Unprecedented Rise of Dynavax Technologies Corporation (NASDAQ:DVAX)

Dynavax Technologies Corporation (DVAX) shares are trading at lower $4.32 and the avg recommendation for the stock is Strong Buy. To add more color...

VYNE Therapeutics Inc. (NASDAQ:VYNE) is Holding Steady

VYNE Therapeutics Inc. (VYNE) shares are trading at higher $1.62 and the avg recommendation for the stock is Strong Buy. To add more color...

The Forecast Just Changed on BEST Inc. (NYSE:BEST)

BEST Inc. (BEST) shares are trading at higher $3.10 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

The Barclays PLC (BCS) shares are trading at higher $5.88 and the avg recommendation for the stock is Strong Buy. while the current analyst price target stands at $6.90.

To add more color to this target, the company’s high over the last year is $10.22 and the low is $3.41. Over the last 52 weeks, BCS is down -42.47% while the S&P 500 is up 0.21%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, BCS reported a profit of $8.05 billion. Barclays PLC also saw revenues increase to $8.05 billion. In addition, BCS has free cash flow of $0.0 as of 03-2020.

BCS Return on Equity (ROE) is 1.10%, and its Return on Assets is 0.10%. All told, it is clear that, BCS needs to be on your watchlist.

Find out when BCS reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. BCS has a short ratio of 1.62 and outstanding shares of 4.32B.

Company Outlook

BCS has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 4.03 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at 0.58. Investors should also keep an eye on sector updates as BCS has historically followed its peers on positive news.

All told, Barclays PLC BCS has strung together solid data and demonstrated underlying fundamentals. At its current valuation, BCS represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

Barclays PLC BCS is now commanding a market cap of 26.32B and a float of 3.93B. BCS is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of BCS stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in BCS, either long or short, and we have not been compensated for this article.

Latest article

Grayscale Bitcoin Trust (OTCMKTS:GBTC) Bid for a New Future

The cryptocurrency space has been in focus in recent weeks due to the price volatility of Bitcoin, the world’s biggest cryptocurrency by...

Inside the Wild Week for DSG Global Inc (OTCMKTS:DSGT)

One of the companies making headlines this week is DSG Global Inc (OTCMKTS:DSGT), and on Thursday there was yet another development that...

Axalta Coating Systems Ltd. (NYSE:AXTA) on the Path to Ruin

Axalta Coating Systems Ltd. (AXTA) shares are trading at lower $21.63 and the avg recommendation for the stock is Moderate Buy, while the current...

Is Now the Time to Invest in Agnico Eagle Mines Limited (NYSE:AEM)?

Agnico Eagle Mines Limited (AEM) shares are trading at higher $78.28 and the avg recommendation for the stock is Moderate Buy, while the current...

AIkido Pharma Inc. (NASDAQ:AIKI) Stock is Plummeting, Here is Why

AIkido Pharma Inc. (AIKI) shares are trading at lower $0.55. To add more color to this target, the company’s high over the last year...